Published in J Biomed Mater Res A on December 12, 2013
D-lactic acidosis: an underrecognized complication of short bowel syndrome. Gastroenterol Res Pract (2015) 0.92
Production of tissue-engineered intestine from expanded enteroids. J Surg Res (2016) 0.77
In situ crosslinkable hyaluronan hydrogels for tissue engineering. Biomaterials (2003) 2.08
Disulfide cross-linked hyaluronan hydrogels. Biomacromolecules (2002) 2.06
Improved cellular infiltration in electrospun fiber via engineered porosity. Tissue Eng (2007) 2.03
Synthesis and evaluation of injectable, in situ crosslinkable synthetic extracellular matrices for tissue engineering. J Biomed Mater Res A (2006) 1.92
Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. Biomaterials (2005) 1.79
Disulfide-crosslinked hyaluronan-gelatin hydrogel films: a covalent mimic of the extracellular matrix for in vitro cell growth. Biomaterials (2003) 1.69
Endothelial nitric oxide synthase in human intestine resected for necrotizing enterocolitis. J Pediatr (2007) 1.54
HB-EGF protects the lungs after intestinal ischemia/reperfusion injury. J Surg Res (2010) 1.51
HB-EGF enhances restitution after intestinal ischemia/reperfusion via PI3K/Akt and MEK/ERK1/2 activation. Gastroenterology (2005) 1.49
Heparin-binding epidermal growth factor-like growth factor decreases the incidence of necrotizing enterocolitis in neonatal rats. J Pediatr Surg (2006) 1.42
Attachment and spreading of fibroblasts on an RGD peptide-modified injectable hyaluronan hydrogel. J Biomed Mater Res A (2004) 1.37
HB-EGF promotes angiogenesis in endothelial cells via PI3-kinase and MAPK signaling pathways. Growth Factors (2007) 1.35
Heparin-binding EGF-like growth factor increases intestinal microvascular blood flow in necrotizing enterocolitis. Gastroenterology (2009) 1.23
Heparin-binding EGF-like growth factor decreases inflammatory cytokine expression after intestinal ischemia/reperfusion injury. J Surg Res (2007) 1.16
Heparin-binding epidermal growth factor-like growth factor promotes enterocyte migration and proliferation in neonatal rats with necrotizing enterocolitis. J Pediatr Surg (2007) 1.15
Heparin-binding EGF-like growth factor downregulates expression of adhesion molecules and infiltration of inflammatory cells after intestinal ischemia/reperfusion injury. J Pediatr Surg (2003) 1.13
HB-EGF stimulates eNOS expression and nitric oxide production and promotes eNOS dependent angiogenesis. Growth Factors (2008) 1.12
Definitive percutaneous treatment of lymphatic malformations of the trunk and extremities. J Pediatr Surg (2008) 1.11
Modulation of embryonic mesenchymal progenitor cell differentiation via control over pure mechanical modulus in electrospun nanofibers. Acta Biomater (2010) 1.11
Heparin-binding epidermal growth factor-like growth factor gene disruption is associated with delayed intestinal restitution, impaired angiogenesis, and poor survival after intestinal ischemia in mice. J Pediatr Surg (2008) 1.11
Heparin-binding EGF-like growth factor protects intestinal stem cells from injury in a rat model of necrotizing enterocolitis. Lab Invest (2011) 1.08
Can we cut the incidence of necrotizing enterocolitis in half--today? Fetal Pediatr Pathol (2010) 1.08
Heparin-binding epidermal growth factor-like growth factor overexpression in transgenic mice increases resistance to necrotizing enterocolitis. J Pediatr Surg (2010) 1.07
Heparin-binding EGF-like growth factor (HB-EGF) and necrotizing enterocolitis. Semin Pediatr Surg (2005) 1.05
Heparin-binding epidermal growth factor-like growth factor is essential for preservation of gut barrier function after hemorrhagic shock and resuscitation in mice. Surgery (2009) 1.04
Heparin-binding EGF-like growth factor (HB-EGF) decreases oxygen free radical production in vitro and in vivo. Antioxid Redox Signal (2002) 1.04
Injectable synthetic extracellular matrices for tissue engineering and repair. Adv Exp Med Biol (2006) 1.03
Upregulation of endogenous heparin-binding EGF-like growth factor (HB-EGF) expression after intestinal ischemia/reperfusion injury. J Invest Surg (2003) 1.02
Preclinical neonatal rat studies of heparin-binding EGF-like growth factor in protection of the intestines from necrotizing enterocolitis. Pediatr Res (2009) 1.01
Heparin-binding epidermal growth factor-like growth factor reduces intestinal apoptosis in neonatal rats with necrotizing enterocolitis. J Pediatr Surg (2006) 1.01
p53 regulates renal expression of HIF-1{alpha} and pVHL under physiological conditions and after ischemia-reperfusion injury. Am J Physiol Renal Physiol (2008) 0.99
Endogenous production of heparin-binding EGF-like growth factor during murine partial-thickness burn wound healing. J Burn Care Rehabil (2002) 0.99
Heparin-binding epidermal growth factor-like growth factor and intestinal ischemia-reperfusion injury. Semin Pediatr Surg (2004) 0.97
Heparin-binding EGF-like growth factor preserves crypt cell proliferation and decreases bacterial translocation after intestinal ischemia/reperfusion injury. J Pediatr Surg (2002) 0.97
Inhibition of NF-kappa B activation and its target genes by heparin-binding epidermal growth factor-like growth factor. J Immunol (2003) 0.97
Effects of extracellular matrix analogues on primary human fibroblast behavior. Acta Biomater (2007) 0.96
Deletion of the heparin-binding epidermal growth factor-like growth factor gene increases susceptibility to necrotizing enterocolitis. J Pediatr Surg (2010) 0.95
Heparin-binding EGF-like growth factor down regulates proinflammatory cytokine-induced nitric oxide and inducible nitric oxide synthase production in intestinal epithelial cells. Nitric Oxide (2002) 0.94
Endothelin-1 in human intestine resected for necrotizing enterocolitis. J Pediatr (2005) 0.94
Heparin-binding epidermal growth factor-like growth factor suppresses experimental liver fibrosis in mice. Lab Invest (2012) 0.93
Fabrication of burst pressure competent vascular grafts via electrospinning: effects of microstructure. J Biomed Mater Res A (2009) 0.93
Tissue distribution and plasma clearance of heparin-binding EGF-like growth factor (HB-EGF) in adult and newborn rats. Peptides (2005) 0.92
Enteric nervous system abnormalities are present in human necrotizing enterocolitis: potential neurotransplantation therapy. Stem Cell Res Ther (2013) 0.91
Mechanical characterization of electrospun polycaprolactone (PCL): a potential scaffold for tissue engineering. J Biomech Eng (2008) 0.91
Intestinal phenotype in mice overexpressing a heparin-binding EGF-like growth factor transgene in enterocytes. Growth Factors (2010) 0.91
Heparin-binding epidermal growth factor-like growth factor and mesenchymal stem cells act synergistically to prevent experimental necrotizing enterocolitis. J Am Coll Surg (2012) 0.91
Postoperative pericardial adhesion prevention using Carbylan-SX in a rabbit model. J Surg Res (2007) 0.91
Synthesis and biological evaluation of a cross-linked hyaluronan-mitomycin C hydrogel. Biomacromolecules (2004) 0.90
The pediatric burn unit: a profit center. J Pediatr Surg (2004) 0.90
Synergistic effects of HB-EGF and mesenchymal stem cells in a murine model of intestinal ischemia/reperfusion injury. J Pediatr Surg (2013) 0.89
HB-EGF promotes intestinal restitution by affecting integrin-extracellular matrix interactions and intercellular adhesions. Growth Factors (2013) 0.89
Aspherical femoral head with highly cross-linked ultra-high molecular weight polyethylene surface cracking. A case report. J Bone Joint Surg Am (2007) 0.89
Contemporary management of benign hepatic adenoma using percutaneous radiofrequency ablation. J Pediatr Surg (2006) 0.88
A silver impregnated antimicrobial dressing reduces hospital length of stay for pediatric patients with burns. J Burn Care Res (2007) 0.88
Structure-function relationships and source-to-ground distance in electrospun polycaprolactone. Acta Biomater (2009) 0.88
Prevalence and partial sequence analysis of human T cell lymphotropic virus type I in China. J Med Virol (2005) 0.88
Heparin-binding epidermal growth factor-like growth factor inhibits cytokine-induced NF-kappa B activation and nitric oxide production via activation of the phosphatidylinositol 3-kinase pathway. J Immunol (2005) 0.88
A silver-impregnated antimicrobial dressing reduces hospital costs for pediatric burn patients. J Pediatr Surg (2007) 0.87
Mice overexpressing the gene for heparin-binding epidermal growth factor-like growth factor (HB-EGF) have increased resistance to hemorrhagic shock and resuscitation. Surgery (2010) 0.87
3-D culture in synthetic extracellular matrices: new tissue models for drug toxicology and cancer drug discovery. Adv Enzyme Regul (2007) 0.87
Innate immune function predicts the development of nosocomial infection in critically injured children. Shock (2014) 0.86
Heparin-binding EGF-like growth factor decreases neutrophil-endothelial cell interactions. J Surg Res (2007) 0.86
Micropatterning and characterization of electrospun poly(ε-caprolactone)/gelatin nanofiber tissue scaffolds by femtosecond laser ablation for tissue engineering applications. Biotechnol Bioeng (2011) 0.86
Heparin-binding EGF-like growth factor is a potent dilator of terminal mesenteric arterioles. Microvasc Res (2009) 0.85
Cross-linked hyaluronan-coated stents in the prevention of airway stenosis. Otolaryngol Head Neck Surg (2006) 0.85
Heparin-binding EGF-like growth factor protects pericytes from injury. J Surg Res (2010) 0.84
Electrospun PCL in vitro: a microstructural basis for mechanical property changes. J Biomater Sci Polym Ed (2009) 0.84
The role of the intestinal microcirculation in necrotizing enterocolitis. Semin Pediatr Surg (2013) 0.84
Gastric outlet obstruction due to adenocarcinoma in a patient with Ataxia-Telangiectasia syndrome: a case report and review of the literature. World J Surg Oncol (2009) 0.83
Hydrogel-electrospun fiber mat composite coatings for neural prostheses. Front Neuroeng (2011) 0.83
Comparative data on child and adolescent cognitive measures associated with depression. J Consult Clin Psychol (2007) 0.83
Three-dimensional laser micrometry characterization of surface wear in total hip arthroplasty. J Biomed Mater Res B Appl Biomater (2007) 0.82
Heparin-binding epidermal growth factor-like growth factor is a potent neurotrophic factor for PC12 cells. Neurosignals (2010) 0.81
HB-EGF improves intestinal microcirculation after hemorrhagic shock. J Surg Res (2010) 0.81
Ser 15 of WEE1B is a potential PKA phosphorylation target in G2/M transition in one-cell stage mouse embryos. Mol Med Rep (2013) 0.81
Timing, route, and dose of administration of heparin-binding epidermal growth factor-like growth factor in protection against intestinal ischemia-reperfusion injury. J Pediatr Surg (2005) 0.81
Heparin-binding epidermal growth factor-like growth factor promotes murine enteric nervous system development and enteric neural crest cell migration. J Pediatr Surg (2012) 0.80
Effects of hydrophobicity and mat thickness on release from hydrogel-electrospun fiber mat composites. J Biomater Sci Polym Ed (2013) 0.80
Heparin-binding EGF-like growth factor (HB-EGF) protects the intestines from radiation therapy-induced intestinal injury. J Pediatr Surg (2013) 0.80
The role of 14-3-3ε interaction with phosphorylated Cdc25B at its Ser321 in the release of the mouse oocyte from prophase I arrest. PLoS One (2013) 0.80
Hydrogel-electrospun fiber composite materials for hydrophilic protein release. J Control Release (2011) 0.80
Heparin-binding epidermal growth factor-like growth factor improves intestinal barrier function and reduces mortality in a murine model of peritonitis. Surgery (2012) 0.80
High-glucose-based peritoneal dialysis solution induces the upregulation of VEGF expression in human peritoneal mesothelial cells: The role of pleiotrophin. Int J Mol Med (2013) 0.79
Heparin-binding epidermal growth factor-like growth factor protects mesenchymal stem cells. J Surg Res (2012) 0.79
Microstructural disassembly of calcium phosphates. J Biomed Mater Res A (2004) 0.78
Human papillomavirus type 58 L1 virus-like particles purified by two-step chromatography elicit high levels of long-lasting neutralizing antibodies. Arch Virol (2012) 0.78
Poly(ADP-ribose) polymerase-1: a novel therapeutic target in necrotizing enterocolitis. Pediatr Res (2011) 0.78
Prevalence and correlates of posttraumatic stress in parents of young children postburn. J Burn Care Res (2013) 0.78
Extracorporeal membrane oxygenation as a lifesaving modality in the treatment of pediatric patients with burns and respiratory failure. J Pediatr Surg (2010) 0.78
Heparin-binding EGF-like growth factor promotes intestinal anastomotic healing. J Surg Res (2010) 0.78
Media-based effects on the hydrolytic degradation and crystallization of electrospun synthetic-biologic blends. J Mater Sci Mater Med (2013) 0.77
Heparin-binding EGF-like growth factor (HB-EGF) overexpression in transgenic mice downregulates insulin-like growth factor binding protein (IGFBP)-3 and -4 mRNA. Growth Factors (2005) 0.77
Inversion appendectomy acting as a lead point for intussusception. Pediatr Surg Int (2008) 0.77
Contact dermatitis caused by baby wipes. J Am Acad Dermatol (2006) 0.77
A technique for systemic mesenchymal stem cell transplantation in newborn rat pups. J Invest Surg (2012) 0.77
Intestinal O2 consumption in necrotizing enterocolitis: role of nitric oxide. Pediatr Res (2006) 0.76
Correction: Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch. PLoS One (2015) 0.75